{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:37:42Z","timestamp":1772109462854,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with standard treatments (fluid restriction and\/or hypertonic saline). Furthermore, we compared the length of hospital stay in the two treatment groups and investigated the occurrence of overcorrection and side effects including osmotic demyelination syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively reviewed 308 transsphenoidal surgical procedures performed between 2011 and 2019 at our hospital. We selected adult patients who developed post-operative SIAD and recorded sodium monitoring, treatment modalities and outcomes. Correction rates were adjusted based on pre-treatment sodium levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-nine patients (9.4%) developed post-operative SIAD. Tolvaptan was administered to 14 patients (median dose 15 mg). Standard treatments were employed in 14 subjects (fluid restriction n=11, hypertonic saline n=1, fluid restriction and hypertonic saline n=2). Tolvaptan yielded higher adjusted sodium correction rates (12.0 mmolL<jats:sup>-1<\/jats:sup>\/24h and 13.4 mmolL<jats:sup>-1<\/jats:sup>\/48h) than standard treatments (1.8 mmolL<jats:sup>-1<\/jats:sup>\/24h, p&amp;lt;0.001, and 4.5 mmolL<jats:sup>-1<\/jats:sup>\/48h, p=0.004, <jats:italic>vs.<\/jats:italic> tolvaptan). The correction rate exceeded 10 mmolL<jats:sup>-1<\/jats:sup>\/24h or 18 mmolL<jats:sup>-1<\/jats:sup>\/48h in 9\/14 and 2\/14 patients treated with tolvaptan, respectively, and in no patient who received standard treatments. No side effects including osmotic demyelination occurred. Tolvaptan was associated with a shorter hospital stay (11<jats:italic>vs.<\/jats:italic>15 days, p=0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Tolvaptan is more effective than fluid restriction (with or without hypertonic saline) and allows for a shortened hospital stay in patients with SIAD after transsphenoidal surgery. However, its dose and duration should be carefully tailored, and close monitoring is recommended to allow prompt detection of overcorrection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.689887","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:21:42Z","timestamp":1621837302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Rita","family":"Indirli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia","family":"Ferreira de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Cremaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea Liliana","family":"Serban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Carosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Tariciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3171\/2008.9.JNS08191","article-title":"Incidence, Clinical Manifestations, and Course of Water and Electrolyte Metabolism Disturbances Following Transsphenoidal Pituitary Adenoma Surgery: A Prospective Observational Study: Clinical Article","volume":"111","author":"Kristof","year":"2009","journal-title":"J Neurosurg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3171\/2013.7.JNS13273","article-title":"Factors Predicting Postoperative Hyponatremia and Efficacy of Hyponatremia Management Strategies After More Than 1000 Pituitary Operations: Clinical Article","volume":"119","author":"Jahangiri","year":"2013","journal-title":"J Neurosurg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000094725","article-title":"Hyponatremia After Transsphenoidal Surgery for Hypothalamo-Pituitary Tumors","volume":"83","author":"Sata","year":"2006","journal-title":"Neuroendocrinology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3171\/jns.2007.106.1.66","article-title":"Recognition and Management of Delayed Hyponatremia Following Transsphenoidal Pituitary Surgery","volume":"106","author":"Zada","year":"2007","journal-title":"J Neurosurg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2019.05.011","article-title":"Sodium Perturbations After Pituitary Surgery","volume":"30","author":"Yuen","year":"2019","journal-title":"Neurosurg Clin N Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1227\/NEU.0000000000001003","article-title":"Delayed Hyponatremia is the Most Common Cause of 30-Day Unplanned Readmission After Transsphenoidal Surgery for Pituitary Tumors","volume":"78","author":"Bohl","year":"2015","journal-title":"Neurosurgery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.endonu.2014.01.005","article-title":"Clinical Guidelines for Management of Diabetes Insipidus and Syndrome of Inappropriate Antidiuretic Hormone Secretion After Pituitary Surgery","volume":"61","author":"Lamas","year":"2014","journal-title":"Endocrinol y Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.amjmed.2016.03.007","article-title":"The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis","volume":"129","author":"Corona","year":"2016","journal-title":"Am J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0160","article-title":"Clinical Practice Patterns for Postoperative Water Balance After Pituitary Surgery","volume":"25","author":"Eisenberg","year":"2019","journal-title":"Endocr Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-444-59602-4.00003-4","article-title":"Disorders of Water Metabolism: Diabetes Insipidus and the Syndrome of Inappropriate Antidiuretic Hormone Secretion","volume":"124","author":"Verbalis","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical Practice Guideline on Diagnosis and Treatment of Hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90575-7","article-title":"Rapid Correction of Severe Hyponatremia With Intravenous Hypertonic Saline Solution","volume":"72","author":"Ayus","year":"1982","journal-title":"Am J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00910207","article-title":"Hypertonic Saline for Hyponatremia: Risk of Inadvertent Overcorrection","volume":"2","author":"Mohmand","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40618-017-0776-x","article-title":"Approach to Hyponatremia According to the Clinical Setting: Consensus Statement From the Italian Society of Endocrinology (Sie), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (Aiom)","volume":"41","author":"Sbardella","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa065181","article-title":"Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and Safety of Oral Tolvaptan Therapy in Patients With the Syndrome of Inappropriate Antidiuretic Hormone Secretion","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/joacp.JOACP_263_17","article-title":"Efficacy of Vaptans for Correction of Postoperative Hyponatremia: A Comparison Between Single Intravenous Bolus Conivaptan vs Oral Tolvaptan","volume":"34","author":"Rajan","year":"2018","journal-title":"J\u00a0Anaesthesiol Clin Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4103\/ija.IJA_581_17","article-title":"Efficacy of Oral Tolvaptan Versus 3% Hypertonic Saline for Correction of Hyponatraemia in Post-Operative Patients","volume":"61","author":"Tosh","year":"2017","journal-title":"Indian J Anaesth"},{"key":"B20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12028-010-9379-5","article-title":"Use of Conivaptan (Vaprisol) for Hyponatremic neuro-ICU Patients","volume":"13","author":"Naidech","year":"2010","journal-title":"Neurocrit Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013503126","article-title":"Conivaptan for Treatment of Hyponatremia in Neurologic and Neurosurgical Adults","volume":"47","author":"Buckley","year":"2013","journal-title":"Ann Pharmacother"},{"key":"B22","first-page":"27","article-title":"Hyponatremia After Trans-Sphenoidal Surgery","volume":"39","author":"Janneck","year":"2014","journal-title":"Minerva Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e318218c78f","article-title":"Use of Intravenous Conivaptan in Neurosurgical Patients With Hyponatremia From Syndrome of Inappropriate Antidiuretic Hormone Secretion","volume":"69","author":"Potts","year":"2011","journal-title":"Neurosurgery"},{"key":"B24","first-page":"P360","article-title":"Use of Tolvaptan for Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma: A Case Report","volume":"29","author":"Ferrante","year":"2012","journal-title":"Endocrine Abstracts"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2018.2018.0182","article-title":"Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma","volume":"11","author":"G\u00fcrb\u00fcz","year":"2019","journal-title":"JCRPE J Clin Res Pediatr Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"bvaa068","DOI":"10.1210\/jendso\/bvaa068","article-title":"Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Resulting From Siadh Following Pituitary Surgery","volume":"4","author":"Kleindienst","year":"2020","journal-title":"J Endocr Soc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40618-016-0463-3","article-title":"Siad: Practical Recommendations for Diagnosis and Management","volume":"39","author":"Cuesta","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-014-0310-9","article-title":"Management of Hyponatremia in Various Clinical Situations","volume":"16","author":"Moritz","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.12.002","article-title":"Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan","volume":"71","author":"Morris","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.4","article-title":"Current Treatment Practice and Outcomes. Report of the Hyponatremia Registry","volume":"88","author":"Greenberg","year":"2015","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"537.e9","DOI":"10.1016\/j.amjmed.2015.11.005","article-title":"Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion","volume":"129","author":"Verbalis","year":"2016","journal-title":"Am J Med"},{"key":"B33","article-title":"Predictors of Outcome in Hospitalized Patients With Severe Hyponatremia","volume":"95","author":"Nzerue","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2006.01294.x","article-title":"Risk Factors for Symptomatic Hyponatraemia: The Role of Pre-Existing Asymptomatic Hyponatraemia","volume":"37","author":"Bissram","year":"2007","journal-title":"Intern Med J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.10.050","article-title":"Vasopressin V2 Receptor Blockade With Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia","volume":"97","author":"Gheorghiade","year":"2006","journal-title":"Am J Cardiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm3041199","article-title":"Incidence, Etiology and Outcomes of Hyponatremia After Transsphenoidal Surgery: Experience With 344 Consecutive Patients At a Single Tertiary Center","volume":"3","author":"Barber","year":"2014","journal-title":"J Clin Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12943","article-title":"Real-Life Experience of Tolvaptan Use in the Treatment of Severe Hyponatraemia Due to Syndrome of Inappropriate Antidiuretic Hormone Secretion","volume":"84","author":"Tzoulis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/nejmra1404489","article-title":"Disorders of Plasma Sodium \u2014 Causes, Consequences, and Correction","volume":"372","author":"Sterns","year":"2015","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/cc11805","article-title":"Clinical Review: Practical Approach to Hyponatraemia and Hypernatraemia in Critically Ill Patients","volume":"17","author":"Overgaard-Steensen","year":"2012","journal-title":"Crit Care"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90518-I","article-title":"Long-Term Neurologic Outcome in Psychogenic Water Drinkers With Severe Symptomatic Hyponatremia: The Effect of Rapid Correction","volume":"88","author":"Cheng","year":"1990","journal-title":"Am J Med"},{"key":"B41","unstructured":"Agenza Italiana Del Farmaco. Registri E Piani Terapeutici"},{"key":"B42","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s11739-016-1508-5","article-title":"Efficacy and Safety of Two Different Tolvaptan Doses in the Treatment of Hyponatremia in the Emergency Department","volume":"12","author":"Castello","year":"2017","journal-title":"Intern Emerg Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.689887\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:21:47Z","timestamp":1621837307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.689887\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":42,"alternative-id":["10.3389\/fendo.2021.689887"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.689887","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"article-number":"689887"}}